<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24755441</article-id>
      <article-id pub-id-type="pmc">3999735</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-12-108</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-12-108</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Surgical treatment of a solitary pulmonary metastasis from eyelid sebaceous carcinoma: report of a case</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Kaseda</surname>
            <given-names>Kaoru</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kaseda@wb4.so-net.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A2">
          <name>
            <surname>Ohtsuka</surname>
            <given-names>Takashi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>t-oh@remus.dti.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Hayashi</surname>
            <given-names>Yuichiro</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>yuichirohayashi72@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Emoto</surname>
            <given-names>Katsura</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>emoto@a7.keio.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Asakura</surname>
            <given-names>Keisuke</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>asakurakeisuke@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Kamiyama</surname>
            <given-names>Ikuo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>i_kami@rc4.so-net.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Goto</surname>
            <given-names>Taichiro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>taichiro@gj9.so-net.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Kohno</surname>
            <given-names>Mitsutomo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kohno@a3.keio.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Surgery, Section of General Thoracic Surgery, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan</aff>
      <aff id="I2"><label>2</label>Department of Pathology, School of Medicine, Keio University, Tokyo, Japan</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>4</month>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <fpage>108</fpage>
      <lpage>108</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>4</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Kaseda et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Kaseda et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.wjso.com/content/12/1/108"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Ocular sebaceous carcinoma is an uncommon, aggressive ocular neoplasm with potential for regional and distant metastasis.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 77-year-old woman was found to have a solitary pulmonary lesion 6&#xA0;years after the initial treatment of sebaceous carcinoma of the eyelid. Video-assisted lung wedge resection of an undetermined pulmonary nodule was carried out successfully. Microscopically, the tumor showed foamy cytoplasm and atypical nuclei, consistent with metastasis of eyelid sebaceous carcinoma.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This is the first case report of resected solitary pulmonary metastasis of eyelid sebaceous carcinoma. Pulmonary resection is a good option for the treatment and diagnosis of metastatic eyelid sebaceous carcinoma.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Sebaceous carcinoma</kwd>
        <kwd>Lung metastasis</kwd>
        <kwd>Solitary metastasis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Sebaceous carcinoma of the eyelid is a relatively rare malignant tumor, and accounts for less than 1% of all eyelid tumors [<xref ref-type="bibr" rid="B1">1</xref>]. As well as being a rare tumor, sebaceous carcinoma can mimic other benign inflammatory and malignant processes, thus errors or delays in diagnosis are not unusual [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. Although local management strategies for this tumor have previously been described [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B10">10</xref>], very few reports have focused on the patterns of metastasis of this tumor and the treatment strategies for such metastases [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Here, we report a case of solitary lung metastasis of eyelid sebaceous carcinoma, and discuss the clinical implication of surgery for a solitary pulmonary metastasis from sebaceous carcinoma.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 77-year-old woman underwent left upper lid resection in April 2006 for sebaceous carcinoma of the eyelid. The surgical margin was negative for cancer cells. In January 2008, she had developed a recurrence in the left upper eyelid, and underwent radiotherapy with a total dose of 57.6&#xA0;Gy of proton beam therapy followed by orbital exenteration of the left eye [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. In July 2012, positron emission tomography&#x2013;computed tomography (PET-CT) revealed a solitary pulmonary nodule 0.5&#xA0;cm in size in the right upper lobe of the patient&#x2019;s lung, which had increased to 1.1&#xA0;cm by September 2013 (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>A). PET-CT revealed a focus of increased uptake in that nodule, with a standardized uptake value of 3.7 (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>B). There was no evidence of other metastatic disease on PET-CT scans. In September 2013, the patient underwent video-assisted thoracoscopic wedge resection of the pulmonary nodule. Frozen sections using oil red O stain revealed accentuation of lipid and presences of foamy cytoplasm in tumor cells, which was positive for lipid staining (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>). Permanent histology demonstrated tumor cells with foamy cytoplasm and atypical nuclei, accompanying numerous lipid globules within the cytoplasm (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>), consistent with metastasis of eyelid sebaceous carcinoma. At the last follow-up, 7&#xA0;months after resection, there was no loco-regional recurrence or distant metastasis of the tumor after surgery.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Computed tomography (CT) and positron emission tomography of the tumors. (A)</bold> Chest CT showed a 1.1&#xA0;cm nodule in the anterior segment of the right upper lobe (arrow). <bold>(B)</bold> PET-CT showed fluorodeoxyglucose accumulation with a Standardized uptake value (SUV) of 3.7 (arrowhead).</p>
        </caption>
        <graphic xlink:href="1477-7819-12-108-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Accentuation of lipid by staining.</bold> The lipid globules have a red color (frozen sections, oil red O, magnification&#x2009;&#xD7;&#x2009;100).</p>
        </caption>
        <graphic xlink:href="1477-7819-12-108-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Sebaceous carcinoma cells.</bold> Foamy and frothy cytoplasm and atypical nuclei, occurred with numerous lipid globules within the cytoplasm of the tumors cells, seen as clear spaces (hematoxylin and eosin, magnification&#x2009;&#xD7;&#x2009;100).</p>
        </caption>
        <graphic xlink:href="1477-7819-12-108-3"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Sebaceous carcinoma of the eyelid refers to a group of carcinomas derived from sebaceous gland cells that occur in the ocular adnexa. It can be invasive in the eyelid and conjunctiva, and can metastasize to regional lymph nodes and distant organs [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Treatment strategies for primary eyelid sebaceous carcinoma are surgery, radiotherapy, and chemotherapy [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Distant hematogenous metastases to the lung, liver, and brain have a mortality rate as high as 30% [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. However, few reports demonstrated the surgical treatment of metastatic eyelid sebaceous carcinoma.</p>
      <p>Standard treatment strategy for pulmonary metastatic sebaceous carcinoma has not yet been established because of the limited number of cases. Chemotherapy regimens in existing reports are largely based on the combination regimens commonly used in the treatment of other forms of poorly differentiated carcinomas of the head and neck region [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Husain <italic>et al</italic>. reported combined chemotherapy of carboplatin and docetaxel for the patient who had multiple lung and lymph node metastases, which resulted in a 30% decrease in tumor size, but the efficacy of this regimen for sebaceous carcinoma has not yet been fully evaluated [<xref ref-type="bibr" rid="B21">21</xref>]. Radiotherapy for primary eyelid sebaceous carcinoma was described in several reports; however, there have been no reports describing radiotherapy for pulmonary metastatic eyelid sebaceous carcinoma [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Resection of pulmonary metastases in patients with sebaceous carcinoma is controversial. However, our case suggests that a surgical approach to lung metastasis of eyelid sebaceous carcinoma could prolong survival in certain subgroups of patients, namely, those with a limited number of metastatic nodules or a significant disease-free interval.</p>
      <p>The possibility of metastasis from eyelid sebaceous carcinoma or primary lung cancer cannot be predicted only on the basis of radiologic findings or disease-free interval. In the present case, we could successfully differentiate solitary lung metastasis of eyelid sebaceous carcinoma from primary lung cancer using oil red O stain, which stains lipid has a red color, on frozen sections.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>We report a rare case of solitary lung metastasis of eyelid sebaceous carcinoma, which was successfully resected and differentiated from primary lung cancer using oil red O stain on frozen sections. Pulmonary resection is a good option for the treatment and diagnosis of metastatic eyelid sebaceous carcinoma.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for the publication of this case presentation and accompanying images. A copy of the written consent is available for the review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>CT: Computed tomography; FDG: Fluorodeoxyglucose; PET: Positron emission tomography.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>KK and TO wrote the manuscript. KK, TO, KA, and IK performed surgery. YH and KE carried out the pathological examination. MK and TG were involved in the final editing. All authors approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cook</surname>
            <given-names>BE</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Bartley</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Cook</surname>
            <given-names>BE</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Bartley</surname>
            <given-names>GB</given-names>
          </name>
          <article-title>Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>2088</fpage>
          <lpage>2209</lpage>
          <comment>quiz 2099&#x2013;2100, 2121</comment>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00796-5</pub-id>
          <pub-id pub-id-type="pmid">11713084</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lai</surname>
            <given-names>TF</given-names>
          </name>
          <name>
            <surname>Huilgol</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Selva</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>CL</given-names>
          </name>
          <article-title>Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma</article-title>
          <source>Dermatol Surg</source>
          <year>2004</year>
          <volume>30</volume>
          <fpage>222</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1524-4725.2004.30069.x</pub-id>
          <pub-id pub-id-type="pmid">14756656</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Leibovitch</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Selva</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Huilgol</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dodd</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>CL</given-names>
          </name>
          <article-title>Intraepithelial sebaceous carcinoma of the eyelid misdiagnosed as Bowen&#x2019;s disease</article-title>
          <source>J Cutan Pathol</source>
          <year>2006</year>
          <volume>33</volume>
          <fpage>303</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="doi">10.1111/j.0303-6987.2006.00423.x</pub-id>
          <pub-id pub-id-type="pmid">16630181</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pereira</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Odashiro</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Rodrigues-Reyes</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Correa</surname>
            <given-names>ZM</given-names>
          </name>
          <name>
            <surname>de Souza Filho</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Burnier</surname>
            <given-names>MN</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Histopathological review of sebaceous carcinoma of the eyelid</article-title>
          <source>J Cutan Pathol</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>496</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="doi">10.1111/j.0303-6987.2005.00371.x</pub-id>
          <pub-id pub-id-type="pmid">16008694</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sinard</surname>
            <given-names>JH</given-names>
          </name>
          <article-title>Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma</article-title>
          <source>Arch Ophthalmol</source>
          <year>1999</year>
          <volume>117</volume>
          <fpage>776</fpage>
          <lpage>783</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.117.6.776</pub-id>
          <pub-id pub-id-type="pmid">10369589</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chao</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Shields</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Krema</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shields</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>1877</fpage>
          <lpage>1883</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00719-9</pub-id>
          <pub-id pub-id-type="pmid">11581065</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shields</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Demirci</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Marr</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Eagle</surname>
            <given-names>RC</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Shields</surname>
            <given-names>CL</given-names>
          </name>
          <article-title>Sebaceous carcinoma of the eyelids: personal experience with 60 cases</article-title>
          <source>Ophthalmology</source>
          <year>2004</year>
          <volume>111</volume>
          <fpage>2151</fpage>
          <lpage>2157</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2004.07.031</pub-id>
          <pub-id pub-id-type="pmid">15582067</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shields</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Demirci</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Marr</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Eagle</surname>
            <given-names>RC</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Shields</surname>
            <given-names>CL</given-names>
          </name>
          <article-title>Sebaceous carcinoma of the ocular region: a review</article-title>
          <source>Surv Ophthalmol</source>
          <year>2005</year>
          <volume>50</volume>
          <fpage>103</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.1016/j.survophthal.2004.12.008</pub-id>
          <pub-id pub-id-type="pmid">15749305</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yen</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Tse</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wolfson</surname>
            <given-names>AH</given-names>
          </name>
          <article-title>Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature</article-title>
          <source>Ophthal Plast Reconstr Surg</source>
          <year>2000</year>
          <volume>16</volume>
          <fpage>211</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1097/00002341-200005000-00008</pub-id>
          <pub-id pub-id-type="pmid">10826762</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wang</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Jou</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Kao</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>MS</given-names>
          </name>
          <article-title>Malignant eyelid tumours in Taiwan</article-title>
          <source>Eye (Lond)</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>216</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.eye.6700231</pub-id>
          <pub-id pub-id-type="pmid">12640409</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zenda</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kawashima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nishio</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kohno</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Nihei</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Onozawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arahira</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ogino</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2011</year>
          <volume>81</volume>
          <fpage>135</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijrobp.2010.04.071</pub-id>
          <pub-id pub-id-type="pmid">20950948</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zenda</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kohno</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kawashima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arahira</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nishio</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tahara</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kishimoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ogino</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2011</year>
          <volume>81</volume>
          <fpage>1473</fpage>
          <lpage>1478</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijrobp.2010.08.009</pub-id>
          <pub-id pub-id-type="pmid">20961697</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ginsberg</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Present Status of Meibomian gland carcinoma</article-title>
          <source>Arch Ophthalmol</source>
          <year>1965</year>
          <volume>73</volume>
          <fpage>271</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.1965.00970030273022</pub-id>
          <pub-id pub-id-type="pmid">14237799</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rao</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Hidayat</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>McLean</surname>
            <given-names>IW</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>LE</given-names>
          </name>
          <article-title>Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data</article-title>
          <source>Hum Pathol</source>
          <year>1982</year>
          <volume>13</volume>
          <fpage>113</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.1016/S0046-8177(82)80115-9</pub-id>
          <pub-id pub-id-type="pmid">7076199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gardetto</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rainer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ensinger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Baldissera</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Piza-Katzer</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Sebaceous carcinoma of the eyelid: a rarity worth considering</article-title>
          <source>Br J Ophthalmol</source>
          <year>2002</year>
          <volume>86</volume>
          <fpage>243</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.86.2.243</pub-id>
          <pub-id pub-id-type="pmid">11815355</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kass</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Hornblass</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Sebaceous carcinoma of the ocular adnexa</article-title>
          <source>Surv Ophthalmol</source>
          <year>1989</year>
          <volume>33</volume>
          <fpage>477</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="doi">10.1016/0039-6257(89)90049-0</pub-id>
          <pub-id pub-id-type="pmid">2658172</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lan</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Lan</surname>
            <given-names>MY</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>CZ</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>CY</given-names>
          </name>
          <article-title>Sebaceous carcinoma of the eyelid with neck metastasis</article-title>
          <source>Otolaryngol Head Neck Surg</source>
          <year>2007</year>
          <volume>136</volume>
          <fpage>670</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="doi">10.1016/j.otohns.2006.08.019</pub-id>
          <pub-id pub-id-type="pmid">17418274</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Boniuk</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>LE</given-names>
          </name>
          <article-title>Sebaceous carcinoma of the eyelid, eyebrow, caruncle, and orbit</article-title>
          <source>Trans Am Acad Ophthalmol Otolaryngol</source>
          <year>1968</year>
          <volume>72</volume>
          <fpage>619</fpage>
          <lpage>642</lpage>
          <pub-id pub-id-type="pmid">5706692</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Midena</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Angeli</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Valenti</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>de Belvis</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Boccato</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil</article-title>
          <source>Br J Ophthalmol</source>
          <year>2000</year>
          <volume>84</volume>
          <fpage>268</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.84.3.268</pub-id>
          <pub-id pub-id-type="pmid">10684836</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yeatts</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Engelbrecht</surname>
            <given-names>NE</given-names>
          </name>
          <name>
            <surname>Curry</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Ford</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Walter</surname>
            <given-names>KA</given-names>
          </name>
          <article-title>5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea</article-title>
          <source>Ophthalmology</source>
          <year>2000</year>
          <volume>107</volume>
          <fpage>2190</fpage>
          <lpage>2195</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(00)00389-4</pub-id>
          <pub-id pub-id-type="pmid">11097594</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Husain</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blumenschein</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Esmaeli</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid</article-title>
          <source>Int J Dermatol</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>276</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-4632.2008.03496.x</pub-id>
          <pub-id pub-id-type="pmid">18289332</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hata</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Koike</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Omura</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Maegawa</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ogino</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2012</year>
          <volume>82</volume>
          <fpage>605</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijrobp.2010.12.006</pub-id>
          <pub-id pub-id-type="pmid">21300468</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Howrey</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Lipham</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Schultz</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Buckley</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Dutton</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Klintworth</surname>
            <given-names>GK</given-names>
          </name>
          <name>
            <surname>Rosoff</surname>
            <given-names>PM</given-names>
          </name>
          <article-title>Sebaceous gland carcinoma: a subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma</article-title>
          <source>Cancer</source>
          <year>1998</year>
          <volume>83</volume>
          <fpage>767</fpage>
          <lpage>771</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19980815)83:4&lt;767::AID-CNCR20&gt;3.0.CO;2-P</pub-id>
          <pub-id pub-id-type="pmid">9708943</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
